Has anyone given thought to this
Atl1102 had great results in the MS trial some 12 years ago..
But due to the clinical hold put on Atl1102 they could not move ahead…
Then there’s the 9 month Tox study which Per had to do.
What does this mean
Well !
Everyone is waiting for a DMD Partner
But
out of the blue a MS Partner could trump DMD .
Very exciting times ahead$$
Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-116
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
